hit counter
USA Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

HAVEN HOSPICE ACQUIRED BY BRIGHTSPRING HEALTH SERVICES

Read more ››
By: PR Newswire Association LLC. - 12 Sep 2024
Related companies:  BrightSpring Health Services Inc.

Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Aura Biosciences, Inc.

Fulcrum Therapeutics Announces Topline Results from Phase 3 REACH Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Fulcrum Therapeutics, Inc.

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Aclarion

Biosplice Therapeutics Announces Initiation of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Trial Sponsored by the National Cancer Institute (NCI)

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Biosplice Therapeutics, Inc.

Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Oruka Therapeutics, Inc.

Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Apogee Therapeutics, LLC

Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Seres Therapeutics, Inc.

Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Lifecore Biomedical, LLC

Invivyd at the Ready for Upcoming Respiratory Virus Season with PEMGARDA™ (pemivibart) to Help Protect Vulnerable Immunocompromised Persons from COVID-19

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Invivyd, Inc.

Oruka Therapeutics Announces $200 Million Private Placement

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Oruka Therapeutics, Inc.

OrthoPediatrics Corp. Announces Launch of Enabling Technologies Division

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  OrthoPediatrics Corp.

VitalCaring’s AI-driven Cognitive Care Pilot Shows Promising Results

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Constant Therapy Health

Sagimet Announces Oral Presentation at the 8th Annual MASH Drug Development Summit

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Sagimet Biosciences

Enable Injections Announces Agreement with Sobi® to Develop and Distribute Aspaveli® in Combination with enFuse® in Sobi Territories

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Enable Injections, Inc.

Intellia Therapeutics to Present Data from the Phase 2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the 2024 ACAAI Annual Scientific Meeting

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Intellia Therapeutics, Inc.

Biogen Board Appoints Two New Independent Directors

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Biogen Inc.

Elevar Therapeutics Reports Advances in HCC and Other Oncology Clinical Programs for Rivoceranib Plus Camrelizumab at the European Society for Medical Oncology Congress 2024

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Elevar Therapeutics, Inc.

Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare Conference

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Keros Therapeutics, Inc.

Acasti to Present at the Life Sciences Investor Forum

Read more ››
By: GlobeNewswire - 12 Sep 2024
Related companies:  Acasti Pharma Inc.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Looking for companies outside of the United States?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • September 2024
    • Philadelphia: BiotechX USA 2024
    • Rockville: 7th Annual BioHealth Capital Region Investment Conference
    • Basel: 11th Annual HealthTech Investment Forum
See Events »
Add an Event »

Latest company news

Novartis Kisqali® shows deepening benefit in new analysis, reducing the risk of recurrence by 28.5% in a broad population of patients with early breast cancer
16 Sep 2024 (GlobeNewswire)

Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer
16 Sep 2024 (GlobeNewswire)

Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
16 Sep 2024 (GlobeNewswire)

Biotechgate database

About Biotechgate
The USA Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com